VIA Pharmaceuticals, Inc.
VIAP
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | -2.47M | -2.12M | -2.09M | -2.92M | -4.25M |
| Total Depreciation and Amortization | 8.40K | 14.10K | 20.50K | 31.90K | 32.70K |
| Total Amortization of Deferred Charges | 997.50K | 362.20K | 188.80K | 10.10K | 1.06M |
| Total Other Non-Cash Items | -49.00K | 142.60K | 291.50K | 510.70K | 285.40K |
| Change in Net Operating Assets | 319.80K | 569.00K | 651.60K | -574.50K | 471.50K |
| Cash from Operations | -1.19M | -1.03M | -940.30K | -2.94M | -2.40M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 1.00M | 1.15M | 600.00K | 1.25M | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 1.30K | -- | -- |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -800.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.00M | 1.15M | 601.30K | 1.25M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -193.90K | 119.60K | -339.00K | -1.69M | -2.40M |